Delivery Order SPE2DB25D3110-SPE2DB26FTCCV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units) with a contract ceiling value of $1,206.33. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $1,009.52 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1 mg capsules (immediate release formulation) in quantities of 100 units. The award, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, carries a firm fixed price and represents a competitively awarded, non-set-aside contract. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100 units, with a ceiling value of $4,545.64. This firm fixed price contract was awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, and represents a non-competitive set-aside delivery order. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tacrolimus 5 mg capsules (100-count units) under a firm fixed-price contract valued at $1,399.92. This non-competitive delivery order, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, represents a single-line pharmaceutical procurement from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. Tacrolimus is an...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,208.18 for 100 capsules of Tacrolimus 1 mg (immediate release) with an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Tacrolimus is an immunosuppressant medication commonly used in transplant patients and those with certain autoimmune...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100, with a contract ceiling value of $3,248.74. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Tacrolimus 1 mg capsules (immediate-release formulation) in quantities of 100 units at a ceiling value of $1,671.70. This is a firm fixed-price delivery order with a completion date of September 23, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competitively awarded...
- The Defense Logistics Agency awarded a $1,926.55 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units). This firm fixed price contract, which is not set-aside, represents a single delivery order against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is AmerisourceBergen's...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide Tacrolimus 1 mg capsules, an immunosuppressant drug, in 100-count unit doses. The contract has a potential value of $1,382.94 and a completion date of January 3, 2024. This delivery order is part of a larger indefinite delivery contract held by Amerisourcebergen Drug Corp to supply pharmaceuticals and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 capsules of 1 mg Tacrolimus, an immunosuppressant medication, with a ceiling value of $10,059.82 and a completion date of May 19, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB26FTCCVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1 mg capsules (immediate-release formulation) in quantities of 100 units, with a ceiling value of $1,183.90. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and was executed on October 23, 2025, with an ultimate completion date of October 24, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen fulfills critical pharmaceutical supply requirements across the defense healthcare system, including support to the Defense Health Agency and U.S. Coast Guard. Tacrolimus is an immunosuppressant medication used primarily in transplant and autoimmune disease management, reflecting the breadth of specialized pharmaceutical commodities the contractor supplies to support military and federal healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/23/25 |